Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) closed at $14.18 down -3.01% from its previous closing price of $14.62. In other words, the price has decreased by -$3.01 from its previous closing price. On the day, 0.53 million shares were traded. DCPH stock price reached its highest trading level at $14.725 during the session, while it also had its lowest trading level at $14.0.
Ratios:
For a deeper understanding of Deciphera Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.59 and its Current Ratio is at 3.80. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On October 30, 2023, Piper Sandler Upgraded its rating to Overweight which previously was Neutral but kept the price unchanged to $23.
Stifel Upgraded its Hold to Buy on August 10, 2023, whereas the target price for the stock was revised from $14 to $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 16 ’24 when Kelly Thomas Patrick sold 3,010 shares for $15.62 per share. The transaction valued at 47,009 led to the insider holds 80,350 shares of the business.
Sherman Matthew L sold 2,615 shares of DCPH for $40,840 on Feb 16 ’24. The EVP & Chief Medical Officer now owns 108,739 shares after completing the transaction at $15.62 per share. On Feb 16 ’24, another insider, Pitman Jama, who serves as the SVP, Chief Development Officer of the company, sold 2,267 shares for $15.62 each. As a result, the insider received 35,405 and left with 68,031 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DCPH now has a Market Capitalization of 1145745408 and an Enterprise Value of 865407872. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.13 while its Price-to-Book (P/B) ratio in mrq is 3.25. Its current Enterprise Value per Revenue stands at 5.298 whereas that against EBITDA is -4.144.
Stock Price History:
Over the past 52 weeks, DCPH has reached a high of $17.73, while it has fallen to a 52-week low of $9.90. The 50-Day Moving Average of the stock is -9.19%, while the 200-Day Moving Average is calculated to be 0.80%.
Shares Statistics:
For the past three months, DCPH has traded an average of 516.28K shares per day and 467170 over the past ten days. A total of 80.50M shares are outstanding, with a floating share count of 50.24M. Insiders hold about 38.85% of the company’s shares, while institutions hold 62.79% stake in the company. Shares short for DCPH as of 1713139200 were 5753285 with a Short Ratio of 11.14, compared to 1710460800 on 5649520. Therefore, it implies a Short% of Shares Outstanding of 5753285 and a Short% of Float of 9.49.
